abstract |
The present invention provides novel anti-AIDS immunotoxins. Immunotoxins include toxins that are chemically bound to monoclonal antibodies against viral reverse transcriptases. It also provides a variety of methods using such novel immunotoxins, including methods for treating a variety of diseases. |